CVS Health Corporation
CVS Health Approves New 2026 Incentive Compensation Plan
Summary
On May 14, 2026, CVS Health Corporation held its Annual Meeting of Stockholders where the company's stockholders approved the 2026 Incentive Compensation Plan (ICP), which replaces the expiring 2017 ICP. The 2026 ICP applies to awards granted after May 14, 2026. Additionally, the meeting saw the election of 13 nominees to the Company's Board of Directors, the ratification of Ernst & Young LLP as the Company's independent registered public accounting firm for 2026, and an advisory approval of the compensation of the Company's named executive officers. A stockholder proposal for reducing the threshold for the Company's stockholder right to act by written consent was not approved.
Profitelligence Alerts
Get alerts for CVS
Be first to know when CVS Health Corporation files with the SEC.
Filing Categories
Advertisement
About CVS Health Corporation
CVS Health Corporation is a leading health services company in the United States, offering a comprehensive range of services aimed at improving healthcare accessibility and convenience. Primarily known for its extensive network of pharmacies, CVS Health operates thousands of retail locations nationwide. These outlets provide prescription medications, over-the-counter drugs, health and wellness products, and immunization services. Beyond retail, CVS Health plays a significant role in the healthcare sector through its pharmacy benefit management division, Caremark, which administers prescription drug plans for insurers and employers. Additionally, the company owns Aetna, a major health insurance provider, aligning its services across retail, pharmacy benefits, and insurance solutions to deliver integrated healthcare experiences. With its broad reach and diverse healthcare offerings, CVS Health Corporation holds a critical place in the healthcare market, continuously working to streamline and enhance the delivery of medical services across the country.
Official SEC Documents
Advertisement